Previous 10 | Next 10 |
In a little over a year, the market has gone from sell "old economy", companies that make something and earn money, to sell companies that don’t make things and earn money. We are now at the stage where nobody cares. don’t buy anything, whether it makes makes "things" or...
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice...
HOUSTON, May 09, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it will report financial results for the first quarter ended March 31, 2022 on Monday, May 16, 2022, before the open of U.S. mar...
Wells Fargo has upgraded Alaunos Therapeutics (NASDAQ:TCRT) to overweight from equal weight citing the company's recent first patient dosing of TCR-T cell therapy in a phase 1/2 trial across multiple solid tumor indications. The firm has a $3 price target (~436% upside based on Tuesday's...
Every retail trader wants to find penny stocks with huge potential. Thanks to the rise of the “Ape” movement, the opportunity in the market was presented during the early days of the pandemic. Weathered stocks like GameStop ( NYSE: GME ) or Bed Bath & Beyond ( NASDAQ...
Preclinical data to be presented highlights the potential ability to generate mbIL-15 TCR-T cells targeting hotspot mutations expressed in solid tumors with enhanced survival capacity HOUSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” o...
First-in-human non-viral TCR-T cell therapy targeting shared hotspot mutations in solid cancers First clinical product manufactured and administered to a patient using the Company’s in house cGMP manufacturing facility Expect to report initial data in 2H22 HOUSTON, ...
Penny stocks are well-known for their potential to produce huge gains for traders. These high-risk, high-reward assets have polarized the retail market. You either love them or try to avoid them at all costs. High levels of volatility have opened doors for crushing drops in price and some o...
Alaunos Therapeutics, Inc. (TCRT) Q4 2021 Earnings Conference Call March 30, 2022, 08:30 AM ET Company Participants Alex Lobo - Chair IR Kevin Boyle - CEO Drew Deniger - VP, Research and Development Mike Wong - VP, Finance Conference Call Participants Chris Howerton - Jeffries Arthur He - HC ...
Alaunos Therapeutics press release (NASDAQ:TCRT): Q4 GAAP EPS of -$0.05 beats by $0.03. As of December 31, 2021, Alaunos had ~$76.1M in cash and cash equivalents. The Company anticipates its cash runway will be sufficient to fund operations into the second quarter of 2023. For further detai...
News, Short Squeeze, Breakout and More Instantly...
Alaunos Therapeutics Inc. Company Name:
TCRT Stock Symbol:
NASDAQ Market:
Alaunos Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...